ESC Premium Access

Glucose lowering agents in the Prevention of Cardiovascular events and Mortality in Type II Diabetes.

Topic: Primary cardiovascular prevention: interventions and outcomes
Sponsored by Cleveland Clinic

Congress Presentation

About the speaker

Doctor Venu Menon

Cleveland Clinic Foundation, Cleveland (United States of America)
7 presentations
0 follower

3 more presentations in this session

What is optimal BP? Key differences and controversies among the many guidelines.

Speaker: Doctor L. Cho (Cleveland, US)


Therapeutic Options Targeting Residual CVD Risk: Current Therapies for the Treatment of Dyslipidemia.

Speaker: Professor S. Nicholls (Melbourne, AU)


Pharmacotherapy Options for Obesity and Cardiometabolic Risk: Helpful or Harmful?

Speaker: Professor S. Nissen (Cleveland, US)


Access the full session

Prevention 360: Strategies for Managing Cardiovascular Risk

Speakers: Doctor V. Menon, Doctor L. Cho, Professor S. Nicholls, Professor S. Nissen

About the event


ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb